Market Signal Briefing

Former Ethereum treasury firm EthZilla has officially rebranded as Forum Markets as it moves ahead with its pivot towards a full-fledged tokenized real-world assets-focused firm.

Summary

Rebranded as Forum Markets, the company will trade under the ticker FRMM from March 2. Under the Forum Markets brand, the company is repositioning itself as a tokenised real-world asset platform. Peter Thiel’s Founders Fund exited its position in the company earlier this month as the stock remained deeply below its August 2025 peak. According to the official announcement, the company has updated its corporate name and brand to Forum Markets as it moves away from its earlier positioning as an Ethereum treasury company. As part of the rebranding, it has also changed its Nasdaq ticker symbol to FRMM and is expected to begin trading under the new symbol on March 2, subject to Nasdaq approval.

Forum framed the move as the “next development in the company’s planned strategic evolution” and said it plans on “connecting traditional capital markets with blockchain-based financial infrastructure.”

“Forum embodies our belief that the next generation of financial markets will be built around institutional-grade, on-chain products backed by real assets, governed by transparency, and delivered through regulated infrastructure,” the company’s chairman and CEO, McAndrew Rudisill, said in an accompanying statement.

The company said its platform is designed to aggregate, structure, and tokenize cash generating real world assets that were previously inaccessible to a broader base of investors. Forum will leverage its subsidiaries and strategic partners to create a repeatable pipeline to originate and distribute tokenized investment products across multiple asset classes.

Forum has already begun phasing out its balance sheet crypto strategy and announced earlier this month that it had acquired two commercial jet engines leased to a “leading US air carrier,” which will underpin its first aviation-backed offering, the Eurus Aero Token I.

ETH treasury plans fail to hold investor attention ETHZilla shares climbed more than 13% after the company announced the rebrand and ticker change. However, on a year-to-date basis, the company’s shares were down over 20% as crypto treasury stocks have struggled to gain traction over the past months.

ETHZilla, formerly a biotech company known as 180 Life Sciences, transitioned into an Ethereum treasury firm last year while crypto treasury stocks were trending. Subsequently, it acquired as much as 102,246 ETH at the height of the strategy, but as the initial enthusiasm faded and share prices retreated, the company later announced its intent to pivot toward the tokenized real-world asset market.

Earlier this month, Peter Thiel’s Founders Fund, an early backer of the company, exited its position. ETHZilla has also moved to sell portions of its assets to scale back its crypto exposure and initiate share buybacks in an effort to stabilise its equity performance.

4 mins mins

Aave has surpassed $1T cumulative lending, here’s what that meansAave’s cumulative lending volume has surpassed $1 trillion, described as the first such milestone for a DeFi protocol, as reported by Cointelegraph. In the same coverage, early institutional users of Aave Horizon were cited as VanEck, WisdomTree, and Securitize, and the protocol was said to have generated about $83.3 million in fees over the past 30 days. These figures frame both the scale of on-chain credit demand and the protocol’s growing fee throughput.

Cumulative lending volume is the all-time sum of loan originations, not the amount currently outstanding or deposited. It can be large even when total value locked or active debt is lower, especially after repayments or market drawdowns.

Crossing the mark indicates durable borrowing demand and operational throughput across multiple market conditions. It does not, by itself, guarantee proportional revenue growth or reduced risk.

Why this milestone matters for DeFi and Aave’s economyAccording to AInvest, the milestone signals Aave’s role as a reusable “utility layer” for on-chain borrowing, while real-world assets (RWAs) and permissioned markets help bridge traditional finance and decentralized infrastructure. This positioning suggests that long-run growth could depend on integrating off-chain assets with on-chain liquidity under clear risk controls.

Aave leadership has framed the protocol as base-layer infrastructure for open finance. “A decade ago, DeFi and Aave didn’t exist. They were just ideas. Today, Aave stands as the backbone of onchain lending,” said Stani Kulechov, CEO of Aave Labs.

Looking ahead, Kulechov has described a broad tokenization opportunity across “abundance assets” such as energy and robotics; according to Coinpaper, he has estimated a potential $30–50 trillion addressable market by 2050. Such forecasts are directional and depend on regulatory clarity, institutional adoption, and standardized collateral frameworks.

The milestone also heightens an ongoing governance conversation about value capture for the DAO versus funding for product development. The outcome of that debate will shape how volume translates into treasury sustainability and broader ecosystem incentives.

BingX: a trusted exchange delivering real advantages for traders at every level.

Institutional participation via Aave Horizon centers on permissioned markets where tokenized RWAs can serve as collateral for stablecoin borrowing; according to Chainlink Today, this “embedded DeFi” model is intended to plug into traditional back-office workflows. As RWA collateral grows, due diligence, custody standards, and reliable pricing oracles become more consequential.

Fee generation scales with utilization, spreads, and liquidations, but conversion to durable DAO revenue depends on parameters and revenue-routing policies. High volumes can coincide with thinner net margins if competition, incentives, or risk buffers compress take rates.

Permissioned RWA markets introduce legal, operational, and counterparty considerations alongside on-chain liquidation mechanics. As activity scales, governance, disclosures, and risk limits need to evolve to keep tail risks bounded.

Cumulative volume vs TVL, active loans, and DAO revenueWhat Aave’s $1T cumulative lending volume measures and how it’s calculatedCumulative lending volume aggregates the notional amount of every loan origination over time across supported markets. Each borrow event is counted at face value; repayments do not reduce the total. The figure is typically derived from transaction-level on-chain logs of borrow and deposit events.

Why volume and protocol revenue can diverge across market cyclesBorrow demand can surge while net fee capture tightens if interest spreads compress, incentives are high, or risk parameters favor utilization over margin. Collateral composition matters: volatile assets, stablecoins, and RWAs carry different risk charges, liquidation profiles, and oracle dependencies. Market stress can also boost liquidation-related flows that are episodic, not steady-state revenue.

FAQ about Aave $1 trillion lending volumeHow does Aave Horizon work and which institutions are using RWAs as collateral?Horizon offers permissioned Aave markets where institutions borrow stablecoins against tokenized RWAs. Early participation has been reported from large asset managers and tokenization platforms.

Is Aave really the first DeFi protocol to cross $1T in lending volume, and how does it compare to rivals?Whether it is “first” depends on each protocol’s disclosed methodology; rankings vary by metric and chain.

DISCLAIMER: The information on this website is provided as general market commentary and does not constitute investment advice. We encourage you to do your own research before investing.

Rate this post

USDC circulation climbed to $75.3 billion as Circle posted strong fourth-quarter growth with revenue rising 77%. The company is advancing its Arc mainnet launch and expanding global stablecoin partnerships.

Trump-backed World Liberty Financial has introduced a new proposal to overhaul its governance through a new Governance Staking System designed to incentivize long-term participation, redirect arbitrage profits to committed token holders, and deepen adoption of its USD1 stablecoin.

Summary

WLFI proposes mandatory staking for unlocked tokens to participate in governance, with ~2% targeted APR for active voters. A new Node and Super Node tier system offers OTC USD1 conversion access and prioritized partnership discussions. The plan aims to redirect stablecoin arbitrage profits from market makers to long-term WLFI ecosystem participants. World Liberty Financial aims to redirect USD1 arbitrage profits to token stakers Under the proposal, holders of unlocked WLFI (WLFI) tokens will be required to stake their tokens in order to participate in governance voting. Staking will carry a minimum lock-up period of 180 days, with voting power determined by a non-linear square root formula that factors in both the amount staked and remaining lock duration.

Governance rights will be dynamic and non-transferable, adjusting as lock-ups decline.

Active participation is central to the design. Stakers must vote at least twice during their lock-up period to qualify for base staking rewards, targeted at roughly 2% APR and paid from the WLFI treasury.

The reward rate will be determined at WLFI’s discretion and is not tied to revenue or operational performance. Only staking participants will receive USD1 deposit incentives on WLFI Markets provided by Dolomite.

The proposal also introduces a tiered structure. “Nodes,” defined as participants staking at least 10 million WLFI, would gain access to over-the-counter USD1 conversion via licensed market makers at 1:1 parity.

World Liberty Financial plans to subsidize these conversions, redirecting arbitrage opportunities previously captured by institutional intermediaries, estimated at 10–15 basis points per cycle.

At the top tier, “Super Nodes” staking 50 million WLFI would receive guaranteed access to the WLFI team for partnership discussions and potential economic incentives, subject to compliance and commercial review.

The proposal requires a quorum of 1 billion eligible WLFI voting tokens and a simple majority to pass, with a seven-day voting window. If approved, implementation will roll out in three phases, beginning with governance staking activation.

Indiana lawmakers have passed House Bill 1042, commonly referred to as the Bitcoin Rights Bill, clearing both legislative chambers and sending the measure to Governor Mike Braun for final approval.

Summary

Indiana’s HB 1042 Bitcoin Rights Bill has passed both legislative chambers and now awaits Governor Mike Braun’s signature. The bill would allow cryptocurrency investment options in public retirement plans and protect individual digital asset access. If signed, the law will take effect July 1, 2026, reflecting growing institutional adoption of Bitcoin. Indiana passes Bitcoin Rights Bill as crypto adoption accelerates If signed into law, the bill will take effect on July 1, 2026, and would allow cryptocurrency investment options within public retirement plans while affirming the rights of individuals to access and use digital assets.

The legislation marks a significant step in formalizing Bitcoin and broader digital asset participation within state-backed financial structures.

The news comes as Arizona lawmakers advanced Senate Bill 1649, which would create a Digital Assets Strategic Reserve Fund allowing the state to hold, invest and potentially lend seized cryptocurrencies.

By permitting exposure to cryptocurrencies in public pension portfolios, Indiana joins a growing list of jurisdictions responding to sustained institutional interest in Bitcoin (BTC), particularly following the strong performance and capital inflows into spot Bitcoin exchange-traded funds over the past several years.

Supporters argue the bill ensures that Indiana’s public institutions and citizens are not disadvantaged as digital assets increasingly become integrated into global financial markets. The measure also reinforces protections for individuals to hold and transact in cryptocurrencies without undue restriction, signaling a pro-innovation stance from state lawmakers.

The push comes amid mounting pressure from financial markets to modernize investment frameworks. Since the launch and expansion of Bitcoin ETFs, institutional adoption has accelerated, prompting policymakers to revisit existing rules around retirement portfolio diversification and digital asset access.

Governor Braun has yet to announce whether he will sign the bill, but if enacted, Indiana would position itself as one of the more crypto-forward states heading into the second half of 2026.

A convincing bullish reversal setup and hints of easing whale distribution may push the price of XRP up by 20% or more in March.

XRP (XRP) is down more than 50% since October 2025, with five consecutive monthly losses. Can March finally snap the bearish streak?

Key takeaways:

XRP’s double-bottom setup targets 20% upside in March.

Whale selling has cooled and larger-holder balances are rising, improving the bullish outlook.

Double bottom hints at 20% XRP rallyAs of Thursday, XRP was forming what appeared to be a double bottom pattern after holding the $1.30–$1.35 support area twice in February.

A double bottom forms when the price hits the same floor twice an rebounds. It resolves on a breakout above the neckline, often setting an upside target equal to the pattern’s height from the breakout level.

XRP/USD daily chart. Source: TradingViewFor XRP, the neckline sits near $1.50. A decisive break above it increases the odds of XRP rising to $1.68–$1.70 by March, roughly 20% above the current levels.

XRP whale flows improve recovery chancesXRP net flows are shrinking toward neutral levels after spending months in distribution phase, according to data resource CryptoQuant.

As of Thursday, the total whale flow on a 90-day moving average was around -3.29 million XRP compared to roughly -33.50 million XRP in December. This shows that whale outflows have substantially decreased despite the 25% price drop in the same period.

XRPL whale flow 90-day moving average vs. price. Source: CryptoQuantAt the same time, XRP supply held by wallets with at least 1,000 tokens has resumed its upward trajectory in recent weeks, suggesting that whales have stopped selling and may be re-accumulating near current lows.

XRP supply held by addresses with at least 1,000 token balance. Source: GlassnodeA similar easing in whale flows occurred in April 2025, which preceded an XRP rebound of over 50%.

Therefore, a clean flip above zero would signal net accumulation and strengthen the case for XRP to follow through toward its $1.68–$1.70 double-bottom target in March.

What could spoil the bullish XRP scenario?The $1.68–$1.70 area is above XRP’s 50-day exponential moving average (50-day EMA, the red trendline), a level the price has failed to break throughout February.

XRP/USD daily price chart. Source: TradingViewA pullback from the 50-day EMA could keep XRP from hitting its double-bottom target. That may further trigger a bear pennant scenario with the price target at around $1, down about 30% from the current price levels.

Macro risks are another headwind. The return of the AI-driven risk-off trade and US–Iran tensions can drain liquidity from high-beta assets, making it harder for XRP to sustain a breakout even if the chart setup currently looks promising.

This article does not contain investment advice or recommendations. Every investment and trading move involves risk, and readers should conduct their own research when making a decision. While we strive to provide accurate and timely information, Cointelegraph does not guarantee the accuracy, completeness, or reliability of any information in this article. This article may contain forward-looking statements that are subject to risks and uncertainties. Cointelegraph will not be liable for any loss or damage arising from your reliance on this information.

Ethereum co-founder Vitalik Buterin has detailed a sweeping technical vision for the network's future. 

The Canadian prodigy has detailed a "Ship of Theseus" style overhaul that will increase transaction speed and secure the blockchain against the threat of quantum computing.

The network's path to faster performance will be linked to a migration toward post-quantum cryptography.

HOT Stories

This comes after Ethereum Foundation researcher Justin Drake released a new roadmap for the popular blockchain. 

The "bundle" strategy Buterin revealed that the Ethereum Foundation consensus upgrades will be paired with switching to quantum-resistant security protocols. Hence, this will not be treated as a separate security upgrade. 

The network will leverage the "invasive" nature of upcoming performance changes to swap out vulnerable cryptographic foundations.

"Because this is a very invasive set of changes, the plan is to bundle the largest step in each change with a switch of the cryptography, notably to post-quantum hash-based signatures, and to a maximally STARK-friendly hash," Buterin wrote.

"Chugging along" Buterin has noted that the network might achieve quantum resistance for its basic block production (slots) before it achieves it for finality. 

This creates a unique fail-safe in the event of a sudden technological leap in quantum computing.

card

"So we may well quite quickly get to a regime where, if quantum computers suddenly appear, we lose the finality guarantee, but the chain keeps chugging along," he said.

The probability of a quantum breakthrough Ethereum co-founder Vitalik Buterin has been one of the crypto industry's most vocal figures regarding the "Q-Day" threat.

In late 2025, he notably estimated a 20% probability that quantum computers capable of breaking current cryptography could emerge before 2030.

The Core Team said they continue with the updates, and the latest is right around the corner.

The Bitcoin price and the overall crypto market have experienced one of their best days in performance since the beginning of the year. This was revealed by analysts who said that since Jane Street was sued, the selling pattern of the company ceased hereby offering relief to digital assets.

Was Jane Street Behind Bitcoin Price Crash? A renowned investigator, Bark, posted on X that the company had been using an algorithm that was crashing down the price of BTC in a bid to buy back at a lower price. Jane Street’s current lawsuit made them stop the manipulation that resulted in the crypto market pump.

“Jane Street was running an algorithm that dumped Bitcoin every single morning at 10am. Every day. For months. Crashing the price. Liquidating retail. Buying back lower. Rinse and repeat,” he said. “The second they got sued it stopped. The 10am dump disappeared. Now Bitcoin just had the best day in months.”

For context, the price of Bitcoin, along with other top cryptocurrencies, recorded a massive surge. This led to the addition of more than $170 billion to the market cap. Additionally, the crypto market cap rose by 7%, reaching $2.4 trillion. Also, the price of BTC rose above $70,000 after weeks of consolidation.

The Jane Street lawsuit was filed this week by the administrator of the liquidation process of Terraform Labs. It was claimed that the company used non-public information obtained from insiders at Terraform Labs to front-run the trades concerning the failure of the Terra-Luna ecosystem developed by Do Kwon.

Experts Back Claim of Market Manipulation Another crypto expert, Nonzee, also shared his analysis supporting the claim of the Bitcoin price dump. He mentioned that for some time, 10 a.m. Eastern time means dump time for the manipulators at the firm. He further said that instead of the coin falling rapidly, it rose higher from 10 am after the filing of the lawsuit related to insider trading.

Source: X Meanwhile, there are no signs to suggest whether Jane Street sells BTC at a particular time of the day. The timing of yesterday’s rally, however, has begun sparking rumors in crypto. This may suggest that one of the primary reasons for the constant selling pressure on Bitcoin may be eliminated.

The recent crash of the crypto market has been harsh. This has been especially evident with the recent crash of the Bitcoin price by more than 50% since October. At the start of the year, experts like Peter Schiff had predicted steeper declines for the coin.

Bloomberg analyst Eric Balchunas was quick to comment on the Jane Street news on X. He concurred with the idea that the firm was behind the daily pressure on the token. He was also optimistic about this being the start of a sustained rebound for the token.

The bogeyman is gone.. That's the vibe rn on CT and in the price action today. I get it too, that big daily dump seemed to kill every rally and everyone's spirit. Is eliminating it enough for a sustained rebound? I guess we'll find out. https://t.co/nOau2SPMbz

— Eric Balchunas (@EricBalchunas) February 25, 2026

Bitcoin touches $70,000 before fading as altcoins lead the strongest bounce in weeksEther, solana, and cardano all outpaced bitcoin on the day, suggesting a rotation into higher-beta tokens as forced selling from the February crash begins to clear.Updated Feb 26, 2026, 5:32 a.m. Published Feb 26, 2026, 5:31 a.m.

Bitcoin came within touching distance of $70,000 on Wednesday before pulling back to around $68,300 in Thursday morning trading, a nearly 5% swing from the session high to the overnight low of $67,700.

The move marks the strongest attempt to reclaim the $70,000 level since the Feb. 5 crash but stopped short of a clean breakout.

The more interesting story was underneath. Altcoins outperformed across the board, with ether up 8.5%, solana gaining 6.9%, cardano surging 10.8%, and dogecoin adding 8.3%. Bitcoin's 4.3% gain was among the smallest in the top 10.

That kind of divergence typically signals risk appetite returning to the edges of the market, where traders chase higher-beta moves once they believe the worst of the selling is done.

"The wave of forced selling is starting to clear out," said Daniel Reis-Faria, CEO of ZeroStack, in an email. "Altcoins are outperforming again, and more of them are ahead of bitcoin. That tells me we're seeing a rotation."

The bounce arrived alongside a muted reaction to Nvidia's quarterly earnings, which beat estimates but failed to sustain a rally. Nasdaq 100 futures slipped 0.3% after the report, and Nvidia shares erased most of their post-earnings gains to edge up just 0.2% in extended trading.

The world's most valuable company signaled concerns about an overheated AI economy, tempering what had been a multi-day recovery in tech stocks.

Meanwhile, the macro backdrop remains fragile for a continued movement in crypto markets. Market maker Wintermute noted that cryptocurrencies have been losing ground alongside tech stocks as capital rotates into defensive and tangible assets.

Crypto finance platform Matrixport flagged stagnation in stablecoin supply as a "significant obstacle" for bitcoin, and onchain data firm Glassnode expects broader liquidity to recover in six months at the earliest.

The near-term risk is straightforward. Cryptoquant data shows selling has slowed on Binance, which supports the case for a short-term bounce. Elsewhere, crypto exchange Bitrue warned that a break below $60,000 could open up a move toward $50,000-$55,000 or even $47,000 if cascading liquidations accelerate.

The gap between the short-term bounce and the medium-term trend remains wide — and Wednesday's rejection at $70,000 did nothing to close it.

More For You

Uniswap’s UNI jumps 15% as governance vote to expand fee switch gains momentum

16 minutes ago

A governance proposal would activate protocol fees across eight additional chains and automate fee collection on all v3 pools, potentially adding an estimated $27 Million in annualized revenue.

What to know:

Uniswap’s UNI token jumped about 15% in 24 hours, outpacing bitcoin and ether, as traders reacted to a governance vote to expand protocol fee capture across multiple layer-2 networks.The proposal would extend the fee switch to eight additional chains, apply a new tier-based v3 fee system to all liquidity pools by default and make protocol fee collection automatic for new pools.Estimates suggest the change could add roughly $27 million in annualized revenue on top of about $34 million already used for UNI burns, deepening Uniswap’s shift into a cross-chain, revenue-generating protocol while raising questions about its competitiveness for liquidity.

Luisa Crawford Feb 26, 2026 06:41

XRP trades at $1.45 with neutral RSI at 45.26. Technical analysis points to $2.50-$3.50 targets by late 2026, requiring break above $1.57 resistance for bullish confirmation.

XRP Price Prediction Summary • Short-term target (1 week): $1.57
• Medium-term forecast (1 month): $1.30-$1.69 range
• Bullish breakout level: $1.57
• Critical support: $1.30

What Crypto Analysts Are Saying About Ripple Recent analyst forecasts present an optimistic outlook for XRP's trajectory through 2026. DeepSeek AI released a prediction on February 25, 2026, stating that "given the severity of the crash that the cryptocurrency had already experienced, the AI estimated a rally through the middle and the second half of 2026 is highly likely. Therefore, it sets its XRP price target for the end of 2026 at $2.80 – 102% above the token's press time price of $1.38."

Forbes provided a more detailed scenario-based Ripple forecast on February 20, 2026, suggesting that with "one or two corridors live, regulatory clarity improves — $2.50 to $4.00. Real on-chain volume begins to emerge, ETF inflows build steadily, and institutional interest formalizes. A breakout and sustained hold above $3.30–$3.60 would signal the market is pricing in durable demand rather than a sentiment rally."

Additionally, AOL reported on February 19, 2026, that "ChatGPT forecasts XRP at $2.50 to $3.50 by late 2026, implying up to 155% upside from current levels near $1.45."

XRP Technical Analysis Breakdown XRP currently trades at $1.45, showing a solid 5.90% gain over the past 24 hours within a trading range of $1.36 to $1.49. The technical landscape presents a mixed but gradually improving picture for this XRP price prediction.

The Relative Strength Index sits at 45.26, placing XRP in neutral territory with room for upward movement before reaching overbought conditions. This neutral RSI reading suggests that XRP hasn't yet attracted excessive buying pressure, potentially leaving space for sustainable price appreciation.

MACD indicators show bearish momentum with a histogram reading of 0.0000, though the convergence between MACD (-0.0705) and its signal line (-0.0705) suggests the bearish trend may be losing steam. The Stochastic oscillator shows %K at 37.41 and %D at 29.93, both in oversold territory, which could indicate a potential reversal opportunity.

Bollinger Bands analysis reveals XRP trading at 0.64 within the bands, closer to the upper band ($1.51) than the lower band ($1.34). The middle band sits at $1.42, closely aligned with current price action. This positioning suggests XRP has room to test the upper band resistance.

Key technical levels show immediate resistance at $1.51 and strong resistance at $1.57, while immediate support lies at $1.37 with strong support at $1.30. The Average True Range of $0.09 indicates moderate volatility, providing opportunities for both swing traders and long-term investors.

Ripple Price Targets: Bull vs Bear Case Bullish Scenario The optimistic case for this XRP price prediction centers on breaking above the $1.57 strong resistance level. A sustained move above this threshold would likely target the 50-day SMA at $1.69, representing a 16.5% upside from current levels.

Beyond the near-term technical targets, the confluence of analyst predictions pointing to $2.50-$3.50 by late 2026 suggests significant upside potential. The bullish scenario requires XRP to reclaim and hold above key moving averages, particularly the 20-day SMA at $1.42, which currently provides modest support.

A break above $1.69 would open the path toward the 200-day SMA at $2.30, aligning with the more conservative end of analyst forecasts. For the highest targets around $3.50-$4.00 to materialize, XRP would need sustained institutional adoption and regulatory clarity as outlined in the Forbes analysis.

Bearish Scenario The bearish case for XRP involves a failure to hold current support levels. Immediate downside risk emerges if XRP breaks below $1.37 support, which could trigger selling toward the strong support zone at $1.30.

A breakdown below $1.30 would invalidate the current consolidation pattern and potentially lead to a retest of lower levels. The bearish momentum indicated by the MACD histogram at 0.0000 suggests limited buying pressure, making XRP vulnerable to broader market weakness.

The significant gap between current price ($1.45) and the 200-day SMA ($2.30) highlights the technical damage from previous declines, requiring substantial fundamental catalysts to bridge this divide for any Ripple forecast to reach analyst targets.

Should You Buy XRP? Entry Strategy Based on current technical conditions, potential XRP buyers should consider a layered approach. The immediate entry opportunity exists around current levels of $1.45, with a stop-loss positioned below the strong support at $1.30 to limit downside risk to approximately 10%.

A more conservative entry strategy involves waiting for a clear break above $1.57 resistance with volume confirmation before initiating positions. This approach reduces risk but may result in missing the initial move.

For risk management, consider position sizing that accommodates the daily ATR of $0.09, allowing for normal volatility while maintaining stop-loss discipline. The neutral RSI reading provides flexibility for both immediate entry and waiting for better technical confirmation.

Dollar-cost averaging into XRP positions over the coming weeks could prove effective, particularly if the price consolidates within the current $1.30-$1.57 range while building momentum for the predicted longer-term targets.

Conclusion This XRP price prediction suggests cautious optimism for Ripple's prospects through 2026. While near-term technical indicators present a mixed picture, the convergence of multiple analyst forecasts pointing to $2.50-$3.50 targets provides a compelling case for patient investors.

The key technical level to watch remains $1.57 resistance. A clean break above this level with sustained volume would validate the bullish thesis and potentially accelerate movement toward the $1.69-$2.30 range. However, failure to hold current support levels could extend the consolidation phase and delay the achievement of higher targets.

Disclaimer: Cryptocurrency price predictions are speculative and based on technical analysis and market sentiment. Past performance does not guarantee future results. Always conduct your own research and consider your risk tolerance before making investment decisions.

Image source: Shutterstock

xrp price analysis xrp price prediction

The bill seeks to open up crypto investment options for public retirement plans and protect digital asset activities on an individual level.

📊
No votes yet – Be the first to vote

Bitcoin touched $70,000 on February 26. The milestone came fast but didn’t last long, with the cryptocurrency retreating within hours as traders shifted focus to alternative digital assets that were posting bigger gains.

Ether jumped hard that day, outpacing Bitcoin’s performance by a wide margin. Solana and Cardano also saw notable rallies, pretty much capturing all the attention from investors who wanted exposure to riskier crypto plays. The altcoin surge happened despite Bitcoin’s brief peak, showing how quickly sentiment can shift in these markets. Trading volumes across major exchanges spiked for these alternative tokens, with many platforms reporting their busiest altcoin trading days in months.

Market analysts cleared up one thing. The forced selling from early February was done.

But Bitcoin’s retreat from $70,000 left room for altcoins to run. Traders didn’t seem too worried about the broader market turbulence – they just moved money around. Ethereum saw particularly strong demand, with futures trading volumes jumping 30% on FTX alone, according to exchange data.

Binance reported notable increases in Solana and Cardano trading volumes on February 26. Both tokens grabbed investor attention while Bitcoin struggled to hold its gains. The exchange saw trading patterns shift dramatically throughout the day, with altcoin activity dominating the platform’s busiest trading hours. Solana’s volume doubled compared to the previous week on Bitfinex, suggesting traders were betting big on its continued growth.

Coinbase’s Chief Economist Alice Smith weighed in on the action. She said: “The recent market dynamics reflect a strong appetite for higher-risk assets right now.” Smith pointed out that altcoins often see sharper price swings, which attracts traders looking for quick profits. Her comments came as Ether trading volume on Kraken surged 25% compared to the week before.

Things shift fast in crypto.

Cameron Winklevoss from Gemini talked about the altcoin resilience during Bitcoin’s wobbly moments. He said: “The current environment presents unique opportunities for altcoins to shine as traders diversify their holdings.” His remarks lined up with what exchanges were seeing – money flowing out of Bitcoin positions and into alternative cryptocurrencies across the board. More on this topic: Altcoin Bloodbath Hits 9 Billion as.

OKX saw a 40% jump in Cardano transactions on February 26, driven by new users joining the platform specifically to trade that token. The exchange noted that Cardano’s expanding ecosystem and recent partnerships were drawing fresh investor interest. Platform data showed many of these new users were coming from traditional finance backgrounds, suggesting institutional interest was building.

Crypto exchanges across the industry reported similar patterns. The shift away from Bitcoin dominance became pretty clear as altcoin transaction volumes climbed throughout the day. Traders seemed focused on capturing potential profits from digital assets that weren’t Bitcoin, basically betting that these alternative tokens would continue outperforming.

Despite Bitcoin’s temporary $70,000 peak, the cryptocurrency faces ongoing challenges to its market dominance. Altcoins have been gaining ground for weeks now, and that trend accelerated on February 26. The diversification into other tokens shows how investors are searching for better opportunities beyond the original cryptocurrency.

Bitcoin’s pullback from $70,000 highlights just how volatile these markets remain. Altcoins capitalized on the instability, attracting more interest from both retail and institutional traders. The crypto market stays unpredictable, with sudden shifts in investor strategies happening almost daily.

Ethereum, Solana, and Cardano’s performance on February 26 really showed the appeal of altcoins right now. These tokens have become attractive alternatives for traders who want exposure to crypto but aren’t convinced Bitcoin will lead the next rally. Their surge points to a dynamic market environment where risk appetite drives most trading decisions.

Major Bitcoin investors haven’t commented publicly on the altcoin rally yet. The lack of response leaves market participants guessing about potential strategic shifts from big players. Any statements from whale investors or institutional holders could influence market perceptions and trading behaviors going forward. More on this topic: Bitcoin Developer Pushes Discord to Ditch.

The crypto landscape keeps shifting as investors get drawn to altcoins while Bitcoin struggles. Trading patterns on February 26 highlighted evolving preferences among traders who are eager to navigate volatile markets effectively. Exchange data suggests this trend might continue if altcoins keep offering compelling returns compared to Bitcoin.

For now, altcoins are stealing the show with their robust performance. Their rise suggests a potential recalibration of investor priorities, with many traders viewing alternative cryptocurrencies as better bets than Bitcoin. The broader crypto market adjusts rapidly to new realities, and February 26 marked another clear example of how quickly sentiment can change.

Future developments remain uncertain as regulatory actions, technological advances, and market sentiment will influence trends. As altcoins gain ground, their role in the broader crypto ecosystem could expand significantly. Market participants are watching closely for further price movements and strategic investments from major players.

Regulatory uncertainty continues weighing on Bitcoin adoption, with the SEC’s delayed decisions on spot ETF applications creating additional headwinds for the flagship cryptocurrency. Meanwhile, Ethereum benefits from clearer regulatory frameworks around its proof-of-stake transition, giving institutional investors more confidence in alternative digital assets.

The February 26 trading patterns mirror broader institutional shifts toward diversified crypto portfolios. Goldman Sachs recently expanded its digital asset trading desk to include more altcoins, while JPMorgan’s blockchain division increased research coverage on Ethereum-based projects. These moves signal growing Wall Street interest in cryptocurrencies beyond Bitcoin.

Post Views: 13

Stakers who vote at least twice during their lock period would earn roughly 2% annualized rewards from the WLFI treasury.

Terrill Dicki Feb 26, 2026 06:59

Dogecoin trades at $0.10 with neutral RSI and bearish MACD momentum. Technical analysis suggests DOGE could target $0.115 on breakout above $0.11 resistance or fall to $0.09 support.

DOGE Price Prediction Summary • Short-term target (1 week): $0.115 • Medium-term forecast (1 month): $0.09-$0.12 range
• Bullish breakout level: $0.11 • Critical support: $0.09

What Crypto Analysts Are Saying About Dogecoin While specific analyst predictions are limited in recent trading sessions, on-chain metrics and historical data patterns provide insights into DOGE's potential trajectory. According to available market data, Dogecoin has shown resilience around current levels with significant trading volume of $147.5 million on Binance spot markets over the past 24 hours.

Recent analysis from blockchain data platforms suggests that DOGE's current positioning near psychological support levels could present both opportunity and risk for traders. The meme coin's 8.34% gain in the last 24 hours indicates renewed interest, though technical indicators remain mixed.

DOGE Technical Analysis Breakdown Dogecoin's technical picture presents a neutral-to-bearish setup with several key indicators worth monitoring. The RSI sits at 47.36, placing DOGE in neutral territory with neither overbought nor oversold conditions present. This suggests the current price action lacks strong directional momentum.

The MACD analysis reveals concerning signals for bulls. With the MACD at -0.0039 and the MACD signal also at -0.0039, the histogram reading of 0.0000 indicates bearish momentum remains intact. This divergence suggests selling pressure could persist in the near term.

Bollinger Bands provide additional context for the DOGE price prediction. Trading at 62% of the Bollinger Band range (0.6221 %B position), Dogecoin sits closer to the upper band ($0.11) than the lower band ($0.09), indicating recent strength despite underlying bearish momentum. The middle band aligns with the 20-day SMA at $0.10, serving as a critical pivot point.

Moving averages paint a mixed picture across timeframes. Short-term EMAs (12 and 26-period) both sit at $0.10, matching current price levels. However, the longer-term perspective shows weakness, with the 200-day SMA at $0.17 significantly above current trading ranges, highlighting the substantial distance DOGE must cover to regain longer-term bullish momentum.

Dogecoin Price Targets: Bull vs Bear Case Bullish Scenario The optimistic Dogecoin forecast hinges on a decisive break above the $0.11 resistance level. This level represents both the immediate resistance and the upper Bollinger Band, making it a critical technical barrier. A sustained move above $0.11 with strong volume could target the $0.115 level, representing a 15% gain from current prices.

For this bullish scenario to materialize, DOGE would need to see the RSI push above 50 into bullish territory while the MACD histogram turns positive. The 24-hour trading range high of $0.11 has already been tested, so bulls need to demonstrate conviction with a clean breakout accompanied by volume expansion.

Bearish Scenario The bearish case for this DOGE price prediction centers on the failure to break $0.11 resistance and subsequent weakness below the $0.10 pivot. Current MACD bearish momentum supports this scenario, with the immediate support at $0.09 serving as the first downside target.

A break below $0.09 would likely accelerate selling toward stronger support levels. The daily ATR of $0.01 suggests relatively contained volatility, but a breakdown could see DOGE testing levels significantly below current ranges. Bears would target psychological support zones with potential for further weakness if broader crypto markets experience selling pressure.

Should You Buy DOGE? Entry Strategy For traders considering DOGE positions, the current technical setup suggests waiting for clearer directional signals. Conservative bulls might consider entries on a confirmed break above $0.11 with stop-losses below $0.10. This approach limits risk while positioning for potential upside toward $0.115.

Alternatively, value-oriented investors could consider accumulation near the $0.09 support level, using tight stops below this zone. This strategy offers better risk-reward ratios but requires patience for price to reach these lower levels.

Risk management remains crucial given the mixed technical signals. Position sizing should account for DOGE's historical volatility and the broader cryptocurrency market's unpredictable nature. The neutral RSI provides flexibility for both bullish and bearish moves, making position timing critical.

Conclusion This Dogecoin forecast suggests DOGE faces a critical juncture at current levels. While the 8.34% daily gain shows renewed interest, underlying technical indicators present mixed signals that warrant caution. The most probable near-term scenario involves continued consolidation between $0.09 and $0.11 until a clear directional catalyst emerges.

Traders should monitor the $0.11 resistance level closely, as a decisive break could trigger the bullish scenario targeting $0.115. Conversely, failure to maintain current levels might see DOGE test $0.09 support. Given the neutral RSI and bearish MACD momentum, maintaining a balanced approach with proper risk management appears prudent.

Disclaimer: Cryptocurrency price predictions are highly speculative and subject to extreme volatility. This analysis is for informational purposes only and should not be considered financial advice. Always conduct your own research and consider your risk tolerance before making investment decisions.

Image source: Shutterstock

doge price analysis doge price prediction

On-chain analytics firm Glassnode has highlighted how accumulation from the large Bitcoin entities has remained relatively weak recently.

Bitcoin Accumulation Trend Score Has Been Struggling To Break 0.5 In a new post on X, Glassnode has talked about the latest trend in the Accumulation Trend Score for Bitcoin. This on-chain indicator tracks whether BTCinvestors are accumulating or distributing right now. The metric calculates its value by looking at the balance changes happening in the wallets of the investors. Additionally, it also accounts for the size of the wallets themselves. This second weighting factor means that larger entities have a stronger influence on the indicator.

When the value of the Accumulation Trend Score is greater than 0.5, it means large investors (or a large number of small entities) are accumulating. The closer the metric is to 1, the stronger this behavior is. On the other hand, the indicator being under 0.5 implies that distribution is the dominant behavior on the network. The extreme point on this side of the scale lies at 0.

Now, here is the chart shared by Glassnode that shows how the Bitcoin Accumulation Trend Score has changed over the course of the cycle:

Accumulation demand has remained weak in the market recently | Source: Glassnode on X As displayed in the above graph, the Bitcoin price crash in November saw the Accumulation Trend Score take on a dark purple color. Here, a light yellow shade on the indicator reflects a value close to zero, while a dark purple one to a value near 1. Thus, it would appear that the market reacted with a near-perfect accumulation behavior to the November price lows.

While December saw continued accumulation, a shift occurred in January; the price recovery rally was met with distribution as the Accumulation Trend Score turned orange-yellow. The cryptocurrency’s price has plummeted since the onset of this selling pressure.

The price crash has been met with some accumulation, but from the chart, it’s visible that the indicator’s color has still only been red. “The Accumulation Trend Score has struggled to push above 0.5 since early February,” noted the analytics firm.

While the current value suggests aggressive distribution is no longer happening, it’s not necessarily a sign of a return of demand for Bitcoin, either. As Glassnode explained, the trend reflects “persistently weak accumulation, particularly among larger entities, signalling that meaningful capital has yet to step back in.” It now remains to be seen how long the current neutral market behavior will continue and which way the next shift will lean.

BTC Price Bitcoin slipped under the $63,000 level on Tuesday, but the market has rebounded since then as the cryptocurrency’s price has returned to $65,300.

The trend in the price of the coin over the last five days | Source: BTCUSDT on TradingView Featured image from Dall-E, chart from TradingView.com

Caroline Bishop Feb 26, 2026 07:11

Polkadot surges 27% to $1.62, breaking above key moving averages. Technical analysis suggests DOT could reach $1.83 resistance within 2-4 weeks if momentum sustains.

Polkadot (DOT) has delivered an impressive 27.74% surge in the past 24 hours, climbing from $1.26 to $1.62 and breaking above several key technical levels. This dramatic move has shifted the short-term outlook for DOT, with technical indicators now pointing toward potential further upside.

DOT Price Prediction Summary • Short-term target (1 week): $1.75-$1.83 • Medium-term forecast (1 month): $1.34-$2.04 range
• Bullish breakout level: $1.83 (immediate resistance) • Critical support: $1.34 (previous resistance turned support)

What Crypto Analysts Are Saying About Polkadot Recent analyst sentiment on Polkadot has shown cautious optimism. Felix Pinkston provided a DOT price prediction on February 24, 2026, stating: "DOT Price Prediction Summary: Short-term target (1 week): $1.29; Medium-term forecast (1 month): $1.19-$1.34 range; Bullish breakout level: $1.34; Critical support: $1.19."

Timothy Morano noted on February 21, 2026: "DOT trades at $1.34 with bullish momentum building. Technical analysis suggests potential move to $1.42 resistance, though bears remain in control below key averages."

Notably, DOT has already exceeded both analysts' bullish targets, with the current price of $1.62 representing a significant breakout beyond their projected levels.

DOT Technical Analysis Breakdown The technical picture for Polkadot has dramatically improved following today's rally. DOT is currently trading at $1.62, well above its 7-day SMA ($1.40) and 20-day SMA ($1.35), indicating strong short-term momentum.

RSI Analysis: The 14-period RSI sits at 58.75, placing DOT in neutral territory with room for further upside before reaching overbought conditions above 70.

MACD Signals: While the MACD histogram shows 0.0000, indicating equilibrium between bullish and bearish momentum, the recent price action suggests this could shift positive if the rally continues.

Bollinger Bands: DOT's position at 1.13 relative to the Bollinger Bands indicates the price has moved well above the upper band ($1.57), suggesting strong momentum but also potential for short-term consolidation.

Key Levels: Immediate resistance stands at $1.83, while strong resistance lies at $2.04. Critical support has established at $1.34, with stronger support at $1.05.

Polkadot Price Targets: Bull vs Bear Case Bullish Scenario In the bullish case, DOT could target $1.83 (immediate resistance) within the next 1-2 weeks, representing a 13% gain from current levels. A break above this level could open the door to $2.04 (strong resistance), offering potential upside of 26%.

For this Polkadot forecast to materialize, DOT needs to: - Maintain trading above $1.57 (former upper Bollinger Band) - See RSI push toward 65-70 without becoming severely overbought - Generate sustained volume above the current 24-hour average of $78.2 million

Bearish Scenario The bearish scenario would see DOT retreat to test the $1.34 support level, representing a 17% decline from current prices. A break below this level could trigger further selling toward $1.05 (strong support), implying downside risk of 35%.

Risk factors include: - Failure to hold above the 20-day SMA ($1.35) on any pullback - RSI divergence if price continues higher without momentum confirmation - Broader cryptocurrency market weakness affecting altcoin sentiment

Should You Buy DOT? Entry Strategy For traders considering DOT positions, the current technical setup offers several strategic entry points:

Conservative Entry: Wait for a pullback to $1.45-$1.50 range (near the EMA 26 at $1.45) before entering long positions.

Aggressive Entry: Current levels around $1.62 for those believing in continued momentum, with tight stop-loss at $1.50.

Aggressive traders: $1.50 (7% risk) Conservative traders: $1.34 (17% risk)

First target: $1.75 (8% gain)

Second target: $1.83 (13% gain) Extended target: $2.04 (26% gain) Conclusion This DOT price prediction suggests Polkadot is positioned for further gains toward $1.83 in the near term, supported by strong technical momentum and a break above key resistance levels. The 27% rally has shifted the technical landscape significantly, with DOT now trading above all short-term moving averages.

However, traders should remain cautious of the extended nature of this move, as the price is currently above the upper Bollinger Band. The Polkadot forecast remains constructive for the next 2-4 weeks, but risk management is essential given the cryptocurrency's volatility.

Disclaimer: Cryptocurrency price predictions are speculative and should not be considered financial advice. Always conduct your own research and consider your risk tolerance before making investment decisions.

Image source: Shutterstock

dot price analysis dot price prediction

The cryptocurrency market is currently digesting the bombshell lawsuit against Jane Street by the bankruptcy estate of Terraform Labs, which alleges insider trading. 

Now, some industry voices are wondering whether or not Jane Street is actually responsible for suppressing the price of the flagship coin. 

Jeff Park, advisor at Bitwise, has concluded that the reality is "trickier than the question" and "more structurally unsettling than the conspiracy theory itself."

HOT Stories

According to Park, the alleged price suppression might be a feature of regulatory architecture itself.

The "grey window" of regulationPark has mentioned a specific regulatory exemption within Regulation SHO, a rule designed to govern short selling. 

Short sellers typically must "locate" shares before shorting to prevent naked shorting, but Jane Street, JPMorgan, and Goldman Sachs are exempt.

You Might Also Like

"This is the grey window: a regulatory carve-out designed for orderly ETF market-making that is, structurally speaking, indistinguishable from a regulatory arbitrage with unmatched duration," Park wrote.

Suppressing price discovery When an ETF trades below its Net Asset Value (NAV), an arbitrage buyer typically steps in to buy the ETF and sell the underlying asset. In the Bitcoin ETF world, however, the AP is the arb buyer.

Park notes that this breaks the natural mechanism that would typically drive spot buying pressure. "The gap cannot close via the natural arb mechanism because the natural arb buyer chose not to buy spot."

The researcher has concluded that no AP explicitly suppresses the Bitcoin price. However, the AP structure can suppress the integrity of the price discovery mechanism.

Skeptics weigh in Park’s analysis sparked a lot of reactions on social media, and some were skeptical. Dave Weisberger, Co-CEO of CoinRoutes, pushed back on the idea that this suppresses price over the long term.

"Empirically, this isn’t true over any substantial time frame," Weisberger argued. "Futures always resolve to spot on expiration." However, Weisberger acknowledged that manipulation remains a concern. 

Keone Hon, CEO of Monad, also challenged the theory. "This conspiracy theory doesn’t hold up," Hon replied. "Hedging short IBIT positions with long futures means that some other party will (on average) end up holding a short futures position that they have to hedge with a long spot position."

Pi Network has completed one year since launching its Open Network, and its founders used the milestone to stress that their focus remains on building infrastructure and real-world use cases rather than chasing short-term price action.

From the very beginning, the project has faced doubt and controversy. Questions about its structure, rollout, and long-term vision have followed it closely, making its first year in the open market anything but quiet.

Pi Co-founder Dr. Nicolas Kokkalis boosts the Pi community with a detailed roadmap of ongoing work on KYC, migration, developer tools, protocol upgrades, and broader ecosystem growth.

While the project’s native token has experienced volatility, the core team continues to push forward with long-term development goals. In a recent video update, Kokkalis laid out how the team is prioritizing work that matters most to Pioneers and builders alike.

“What Pi Is Working On Now”According to Kokkalis, the immediate priorities remain KYC verification and mainnet migration, which he described as fundamental to Pi’s broader vision. He explained that the team is increasing KYC throughput and speeding up verification processes, including “unblocking more users” and integrating advanced technologies like AI into the flow. This, he noted, will help more Pioneers fully participate in the Mainnet ecosystem without unnecessary delays.

“KYC and migration remain a top priority,” Kokkalis said, highlighting that completing identity verification is essential for ensuring the network’s integrity and enabling real usage of Pi tokens. He also mentioned expected KYC validator rewards coming soon, which aim to incentivize community participation and broaden verification coverage.

Building Tools for DevelopersBeyond migration and identity work, Kokkalis stressed the importance of improving developer tools that make it easier to build on Pi’s blockchain. 

“We’re lowering the barrier to building on Pi,” he said, noting that new utilities such as faster payment integrations and expanded development environments will help creators launch real applications.

This push aligns with the broader ecosystem’s growth; recent data shows Pi’s Mainnet now supports hundreds of live apps, and over 300 applications are reported running on the network.

Protocol Upgrades and InfrastructureKokkalis also touched on deeper technical work, including upgrades to the network protocol, node infrastructure, and future decentralized exchange (DEX) and liquidity pool components. These upgrades aim to transition Pi from a mobile mining project toward a fully functioning blockchain capable of supporting broad decentralized finance and commerce activity.

Utility Over HypeFounders have repeatedly stressed that Pi’s approach is about utility and real use cases rather than speculation. This philosophy underpins the network’s design choices, from fully KYC-verified participation to ecosystem token models tied to real application usage rather than simple trading.

Trust with CoinPedia:CoinPedia has been delivering accurate and timely cryptocurrency and blockchain updates since 2017. All content is created by our expert panel of analysts and journalists, following strict Editorial Guidelines based on E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness). Every article is fact-checked against reputable sources to ensure accuracy, transparency, and reliability. Our review policy guarantees unbiased evaluations when recommending exchanges, platforms, or tools. We strive to provide timely updates about everything crypto & blockchain, right from startups to industry majors.

Investment Disclaimer:All opinions and insights shared represent the author's own views on current market conditions. Please do your own research before making investment decisions. Neither the writer nor the publication assumes responsibility for your financial choices.

Sponsored and Advertisements:Sponsored content and affiliate links may appear on our site. Advertisements are marked clearly, and our editorial content remains entirely independent from our ad partners.

Journalist

Posted: February 26, 2026

Solana has started to show strength after a brief period of weakness.

While broader markets struggled, SOL stabilized as bulls stepped back in with conviction. The $75-zone acted as the line in the sand, and buyers defended it aggressively, preventing a deeper breakdown.

This defense signaled that sellers were losing control near support. Therefore, attention shifted towards whether on-chain strength could justify renewed optimism.

At the time of writing, momentum was no longer collapsing. It was rebuilding with intent. This was evident on the price charts, with SOL valued at $88 following a 7% hike in 24 hours. 

Solana dominates weekly DEX volume Solana [SOL] commanded trading activity across decentralized exchanges this week.

Top 10 Chains by DEX Volume in the last 7 days showed Solana leading at $15.72 billion. Ethereum followed at $11.64 billion, while BNB Chain trailed at $6.21 billion.

Source: X

Base recorded $5.17 billion, Arbitrum posted $1.87 billion, and Polygon hit figures of $1.48 billion. All while Avalanche logged $999.78M, while Sui and Monad remained below $700M.

The gap was clear and apparent. That may be why liquidity has been so aggressively concentrated on Solana’s network.

Such dominance can also be seen as evidence of active capital rotation, rather than passive speculation.

Are TVL surges a sign of ecosystem acceleration? TVL growth data revealed sharp inflows into select Solana protocols.

SuperstateInc surged 97.23% in 7-day TVL growth. KnightradeTeam followed at 96.42%, nearly matching that explosive pace.

Source: X

The disparity when compared to other pools seemed steep though. dflow hiked by “only” 18.75%, while etherfuse recorded figures of 14.56%. Similarly, other protocols ranged between 3.55% and 14.13%, including HastraFi and solsticefi.

This implied that momentum has been highly concentrated at the top. Also, those near-100% jumps signaled aggressive capital deployment.

Despite the concentration though, growth is undeniable. Needless to say, this has led to renewed conviction inside the ecosystem.

$75 holds as bulls reclaim the EMA ribbon The $75-level held firmly under pressure.

Bulls defended that zone decisively, preventing structural damage. As a result, SOL reclaimed the $80s with authority. More importantly, the price moved back above the EMA ribbon. Therefore, short-term momentum shifted towards buyers.

Source: TradingView

Holding above the EMA ribbon gave bulls leverage. In fact, the RSI showed Solana recovering from the oversold zone. Failure to maintain that position would have invited immediate weakness.

Put simply, technical recovery finally mirrored ecosystem expansion.

Will SOL sustain momentum above the EMA? Now, despite the shift in momentum, sustainability remains the real test. Reclaiming the EMA ribbon altered sentiment quickly. However, at press time, SOL still needed to clear the $90-resistance convincingly.

Solana has the fuel. Looking ahead, consistency matters more than excitement. Should support hold and the $90-level break, momentum could extend further.

Final Summary Solana’s $15.72 billion DEX volume confirmed aggressive liquidity leadership.
Defending $75 and reclaiming the EMA ribbon on the price charts marked a decisive shift for SOL. 

As Bitcoin enthusiasts question why the digital asset hasn’t yet hit the $150,000 milestone despite massive ETF inflows, Jeff Park, Head of Alpha Strategies at Bitwise, has provided a sobering look at the plumbing of the financial system.

Summary

Jeff Park, Head of Alpha Strategies at Bitwise, argues Bitcoin’s failure to hit $150,000 isn’t manipulation but ETF structure. Authorized Participants (APs) can hedge ETF exposure using futures instead of buying spot Bitcoin, weakening the direct link between ETF inflows and price appreciation. The shift to in-kind redemptions and OTC sourcing may reduce public exchange buying pressure, potentially muting Bitcoin’s explosive upside. Bitwise’s Jeff Park says Bitcoin ETFs, not Wall Street, are capping BTC price In a detailed post on X, Park argues that the “villain” isn’t a single firm like Jane Street, but rather the structural architecture of the Bitcoin (BTC) ETF itself.

Everyone is asking: "Is Jane Street why Bitcoin isn't at $150k?"

As expected, the answer is trickier than the question. But it's also more structurally unsettling than the conspiracy theory itself—and once you understand the actual mechanics, you won't be able to unsee them👇 pic.twitter.com/iLEeJpDeo4

— Jeff Park (@dgt10011) February 25, 2026 According to Park, Authorized Participants (APs) operate within a “grey window” of Regulation SHO. While standard traders must locate shares before shorting, APs are exempt due to their role in creating and redeeming ETF shares.

This allows them to maintain positions with a level of capital efficiency and duration that is “indistinguishable from a regulatory arbitrage.”

The most critical revelation involves how these institutions hedge. Typically, an arbitrageur would buy spot Bitcoin to close a price gap.

However, if an AP chooses to hedge using Bitcoin futures instead of the underlying asset, the “spot was never bought.” This breaks the link between ETF demand and spot price appreciation.

Furthermore, the recent transition to “in-kind” redemptions has removed the “structural governor” that previously forced spot buying. APs can now source Bitcoin through private OTC desks with minimal market impact, effectively bypassing the public exchanges where price discovery happens.

Park concludes that while no firm is explicitly “manipulating” the market, the current regulatory framework, designed for traditional assets, is fundamentally at odds with Bitcoin’s mission.

The result is a system where the “middle” of the trade escapes categorization, potentially muffling the explosive price growth investors expected.

IMAX Corporation (IMAX) Q4 2025 Earnings Call Transcript

February 26, 2026 00:30 ET  | Source: argenx SE

Study met primary endpoint (p-value = 0.012)First registrational study to specifically evaluate a targeted treatment for patients living with ocular MG Results support planned Supplemental Biologics License Application (sBLA) submission to U.S. Food and Drug Administration (FDA) to expand label into oMG Regulated Information – Inside Information 

February 26, 2026, 6:30 AM CET  

Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced positive topline results from the Phase 3 ADAPT OCULUS study evaluating VYVGART® (efgartigimod alfa and hyaluronidase-qvfc) in adults with ocular myasthenia gravis (oMG).

ADAPT OCULUS met its primary endpoint (p-value=0.012), showing that patients living with oMG and treated with VYVGART demonstrated statistically significant improvement from baseline in Myasthenia Impairment Index (MGII) Patient Reported Outcome (PRO) ocular scores at Week 4 compared to placebo. In the overall population, mean change from baseline in patients treated with VYVGART was a 4.04 point improvement in MGII PRO versus a mean change of 1.99 MGII PRO score in patients treated with placebo. Patients treated with VYVGART experienced a marked reduction of key ocular symptoms: diplopia (double vision) and ptosis (drooping of the upper eyelids).

“Ocular myasthenia gravis significantly impacts patients’ daily lives, affecting vision, independence and the ability to do routine tasks, such as work or drive a car. Yet today, there are no approved targeted medicines for this disease,” said Carolina Barnett-Tapia, M.D., Ph.D., Associate Professor of Medicine (Neurology) at the University of Toronto. “The improvements observed with VYVGART in the OCULUS trial offer hope to the thousands of myasthenia gravis patients with ocular involvement.”

VYVGART was well tolerated and had a favorable safety profile in patients with oMG, consistent with prior studies. No new safety concerns were identified.

“ADAPT OCULUS is the first registrational study specifically designed to evaluate a targeted therapy for ocular myasthenia gravis,” said Luc Truyen, M.D., Ph.D., Chief Medical Officer of argenx. “Ocular MG has been historically under-studied and represents a significant unmet need in the MG community. These positive results deliver on our patient-centered approach to drug development and bring us one step closer to our vision of delivering a targeted, transformative treatment option to as many MG patients as possible and ensuring no patient is left behind.”

Data from the ADAPT OCULUS study will be presented at an upcoming medical meeting.

About the ADAPT OCULUS Study Design

ADAPT OCULUS is a Phase 3, randomized, double-blind, placebo-controlled, parallel-group design study evaluating the efficacy and safety of VYVGART SC administered by prefilled syringe in adult patients with ocular MG (MGFA Class I) (n=141) across North America, Europe and Asia-Pacific. In Part A, randomized participants (1:1) received four once-weekly injections of efgartigimod PH20 SC or placebo PH20 SC followed by a 4-week follow-up. In Part B, open-label extension, participants received 2 cycles of four once-weekly efgartigimod injections with a 4-week interval between cycles. Additional cycles from Cycle 3 onward could start ≥1 week after the last administration of the previous cycle, based on clinical status.

The primary endpoint was the change from baseline in Myasthenia Gravis Impairment Index (MGII) (patient-reported outcome [PRO] subcomponent) ocular score at week 4 (day 29) compared to placebo in Part A. Enrolled participants were either seropositive or seronegative for AChR-Ab, and MGFA Class I with only ocular muscle weakness as determined by an MGII (PRO) ocular score of ≥6 with at least 2 ocular items with a score of ≥2. Participants were on a stable dose of gMG treatment prior to randomization, including acetylcholinesterase inhibitors, corticosteroids or nonsteroidal immunosuppressive drugs.

MGII is a validated measure of disease severity based on the signs and symptoms of myasthenia gravis and includes an ocular-specific subdomain that evaluates the two key clinical symptoms of oMG: diplopia and ptosis.

Important Safety Information  

What is VYVGART® (efgartigimod alfa-fcab)? 
VYVGART is a prescription medicine used to treat a condition called generalized myasthenia gravis, which causes muscles to tire and weaken easily throughout the body, in adults who are positive for antibodies directed toward a protein called acetylcholine receptor (anti-AChR antibody positive).

 IMPORTANT SAFETY INFORMATION 
Do not use VYVGART if you have a serious allergy to efgartigimod alfa or any of the other ingredients in VYVGART. VYVGART can cause serious allergic reactions and a decrease in blood pressure leading to fainting.

 VYVGART may cause serious side effects, including: 

Infection. VYVGART may increase the risk of infection. The most common infections were urinary tract and respiratory tract infections. Signs or symptoms of an infection may include fever, chills, frequent and/or painful urination, cough, pain and blockage of nasal passages/sinus, wheezing, shortness of breath, fatigue, sore throat, excess phlegm, nasal discharge, back pain, and/or chest pain. Allergic Reactions (hypersensitivity reactions). VYVGART can cause allergic reactions such as rashes, swelling under the skin, and shortness of breath. Serious allergic reactions, such as trouble breathing and decrease in blood pressure leading to fainting have been reported with VYVGART.  Infusion-Related Reactions. VYVGART can cause infusion-related reactions. The most frequent symptoms and signs reported with VYVGART were high blood pressure, chills, shivering, and chest, abdominal, and back pain.  Tell your doctor if you have signs or symptoms of an infection, allergic reaction, or infusion-related reaction. These can happen while you are receiving your VYVGART treatment or afterward. Your doctor may need to pause or stop your treatment. Contact your doctor immediately if you have signs or symptoms of a serious allergic reaction.

 Before taking VYVGART, tell your doctor if you: 

take any medicines, including prescription and non-prescription medicines, supplements, or herbal medicines, have received or are scheduled to receive a vaccine (immunization), or have any allergies or medical conditions, including if you are pregnant or planning to become pregnant, or are breastfeeding.  What are the common side effects of VYVGART? 
The most common side effects of VYVGART are respiratory tract infection, headache, and urinary tract infection.

These are not all the possible side effects of VYVGART. Call your doctor for medical advice about side effects. You may report side effects to the US Food and Drug Administration at 1-800-FDA-1088. 

Please see the full Prescribing Information for VYVGART and talk to your doctor. 

Important Safety Information 

What is VYVGART HYTRULO® (efgartigimod alfa and hyaluronidase-qvfc)?

VYVGART HYTRULO is a prescription medicine used to treat adults with:

generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive.chronic inflammatory demyelinating polyneuropathy (CIDP). It is not known if VYVGART HYTRULO is safe and effective in children.

IMPORTANT SAFETY INFORMATION 
Do not take VYVGART HYTRULO if you are allergic to efgartigimod alfa, hyaluronidase, or any of the ingredients in VYVGART HYTRULO. VYVGART HYTRULO can cause serious allergic reactions and a decrease in blood pressure leading to fainting.

 Before taking VYVGART HYTRULO, tell your healthcare provider about all of your medical conditions, including if you:

have an infection or fever.have recently received or are scheduled to receive any vaccinations.have any history of allergic reactions.have kidney (renal) problems.are pregnant or plan to become pregnant. It is not known whether VYVGART HYTRULO will harm your unborn baby. Pregnancy Exposure Registry. There is a pregnancy exposure registry for women who use VYVGART HYTRULO during pregnancy. The purpose of this registry is to collect information about your health and your baby. Your healthcare provider can enroll you in this registry. You may also enroll yourself or get more information about the registry by calling 1-855-272-6524 or going to VYVGARTPregnancy.com are breastfeeding or plan to breastfeed. It is not known if VYVGART HYTRULO passes into your breast milk. Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

VYVGART HYTRULO can cause side effects which can be serious, including:

Infection. VYVGART HYTRULO may increase the risk of infection. If you have an active infection, your healthcare provider should delay your treatment with VYVGART HYTRULO until your infection is gone. Tell your healthcare provider right away if you get any of the following signs and symptoms of an infection: fever, chills, frequent and painful urination, cough, pain and blockage or nasal passages, wheezing, shortness, sore throat, excess phlegm, nasal discharge.Allergic reactions (hypersensitivity reactions). VYVGART HYTRULO can cause allergic reactions that can be severe. These reactions can happen during, shortly after, or weeks after your VYVGART HYTRULO injection. Tell your healthcare provider or get emergency help right away if you have any of the following symptoms of an allergic reaction: rash, swelling of the face, lips, throat, or tongue, shortness of breath, hives, trouble breathing, low blood pressure, fainting.Infusion or injection-related reactions. VYVGART HYTRULO can cause infusion or injection-related reactions. These reactions can happen during or shortly after your VYVGART HYTRULO injection. Tell your healthcare provider if you have any of the following symptoms of an infusion or injection-related reaction: high blood pressure, chills, shivering, chest, stomach, or back pain. The most common side effects of VYVGART HYTRULO include respiratory tract infection, headache, urinary tract infection, and injection site reactions.

These are not all the possible side effects of VYVGART HYTRULO. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Please see the full Prescribing Information for VYVGART HYTRULO and talk to your doctor. 

About VYVGART and VYVGART Hytrulo

VYVGART® (efgartigimod alfa fcab) is a first-in-class human IgG1 antibody fragment that binds to the neonatal Fc receptor (FcRn), resulting in the reduction of circulating IgG autoantibodies. VYVGART® Hytrulo is a subcutaneous combination of efgartigimod alfa (VYVGART) and recombinant human hyaluronidase PH20 (rHuPH20), Halozyme’s ENHANZE® drug delivery technology to facilitate subcutaneous injection delivery of biologics. VYVGART is approved for generalized myasthenia gravis (gMG) and immune thrombocytopenia (Japan only). VYVGART Hytrulo is approved for gMG and chronic inflammatory demyelinating polyneuropathy (CIDP). VYVGART Hytrulo may be marketed under different proprietary names in other regions.

About Ocular Myasthenia Gravis (oMG)

Ocular myasthenia gravis (oMG) is a rare and chronic autoimmune disease characterized by muscle weakness limited to the muscles controlling the eyes and eyelids. Symptoms commonly include ptosis (drooping eyelids), diplopia (double vision), and fluctuating visual disturbance that can impair daily activities. Approximately 80% of myasthenia gravis (MG) patients initially present with ocular symptoms, and up to 92% experience ocular involvement at some point during the course of disease. While many progress to generalized myasthenia gravis (gMG), in 15–25% of patients, weakness remains restricted to the ocular muscles. oMG is driven by pathogenic IgG autoantibodies that disrupt communication at the neuromuscular junction. Despite the functional and quality-of-life burden associated with persistent ocular symptoms, there are currently no approved targeted therapies specifically for oMG. Treatment approaches often rely on symptomatic therapies and generalized immunosuppression, underscoring the need for additional therapeutic options for this distinct MG population.

About argenx

argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx developed and is commercializing the first approved neonatal Fc receptor (FcRn) blocker and is evaluating its broad potential in multiple serious autoimmune diseases while advancing several earlier stage experimental medicines within its therapeutic franchises. For more information, visit  www.argenx.com  and follow us on LinkedIn, Instagram, Facebook, and YouTube.

This press release contains inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation (Regulation 596/2014).

Media:
Colin McBean
[email protected]

Investors:
Alexandra Roy
[email protected]

FORWARD LOOKING STATEMENTS
The contents of this announcement include statements that are, or may be deemed to be, “forward-looking statements.” These forward-looking statements can be identified by the use of forward-looking terminology, including the terms “advance,” “commit,” “continue,” “develop,” “potential,” and “will” and include statements argenx makes concerning the potential of VYVGART for oMG patients; argenx’s vision of delivering a targeted, transformative treatment option to as many MG patients as possible; its expectation that it will submit a Supplemental Biologics License Application (sBLA) for VYVGART for oMG to the U.S. FDA by end of third quarter 2026; its commitment to improve the lives of people suffering from severe autoimmune diseases; its plan to present data from the ADAPT OCULUS study at an upcoming medical meeting; its aim to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines; its commercialization of the first approved neonatal Fc receptor (FcRn) blocker and evaluation of its broad potential in multiple serious autoimmune diseases; and its advancement of several earlier stage experimental medicines within its therapeutic franchises. By their nature, forward-looking statements involve risks and uncertainties and readers are cautioned that any such forward-looking statements are not guarantees of future performance. argenx’s actual results may differ materially from those predicted by the forward-looking statements as a result of various important factors, including but not limited to, the results of argenx’s clinical trials; expectations regarding the inherent uncertainties associated with the development of novel drug therapies; preclinical and clinical trial and product development activities and regulatory approval requirements; the acceptance of its products and product candidates by its patients as safe, effective and cost-effective; the impact of governmental laws and regulations, including tariffs, export controls, sanctions and other regulations on its business; its reliance on third-party suppliers, service providers and manufacturers; inflation and deflation and the corresponding fluctuations in interest rates; and regional instability and conflicts. A further list and description of these risks, uncertainties and other risks can be found in argenx’s U.S. Securities and Exchange Commission (SEC) filings and reports, including in argenx’s most recent annual report on Form 20-F filed with the SEC as well as subsequent filings and reports filed by argenx with the SEC. Given these uncertainties, the reader is advised not to place any undue reliance on such forward-looking statements. These forward-looking statements speak only as of the date of publication of this document. argenx undertakes no obligation to publicly update or revise the information in this press release, including any forward-looking statements, except as may be required by law.

A logo of defense supplier Hensoldt AG is pictured during Hensoldt's initial public offering (IPO) at the Frankfurt Stock Exchange in Frankfurt, Germany, September 25, 2020. REUTERS/Ralph... Purchase Licensing Rights, opens new tab Read more

Feb 26 (Reuters) - German defence contractor Hensoldt (HAGG.DE), opens new tab on Thursday reported full-year revenue slightly below market expectations but a surge in high-value orders and strong backlog demonstrated its gains from Europe's rearmament push.

The sensors and electronic warfare specialist reported 2025 revenue of 2.46 billion euros ($2.90 billion), below the 2.50 billion euro company-compiled consensus. The shortfall occurred despite what executives described as structurally rising demand, supported by Germany's defense reset and steady procurement activity by its NATO allies.

Make sense of the latest ESG trends affecting companies and governments with the Reuters Sustainable Switch newsletter. Sign up here.

"The geopolitical situation is forcing Europe to sustainably strengthen its defence capabilities," CEO Oliver Doerre said in a statement. "Germany has taken on a key role here and has been a major driver of our order intake momentum in 2025."

Germany retains a 25.1% golden share in the company, reflecting its sensitivity as a national security asset, while Italy's Leonardo (LDOF.MI), opens new tab holds roughly 23%.

Profitability remained resilient. Adjusted earnings before interest, taxes, depreciation and amortisation (EBITDA) rose to 452 million euros, reflecting a margin of 18.4%, in line with expectations and above the company's own forecast.

Order intake jumped 62% to 4.71 billion euros, lifting its order backlog to 8.83 billion euros.

Still, the numbers highlight Hensoldt's constraints. Supply chain tightness in electronic components and ongoing hiring bottlenecks continue to shape the pace at which it can convert its backlog into revenue.

For 2026, Hensoldt forecast revenue of about 2.75 billion euros and set an adjusted margin target of 18.5%-19.0%.

Management also reiterated expectations for a sustained book-to-bill ratio in the 1.5-2.0 range -- a signal that it sees no cooling in demand for its radar, electronic warfare and optoelectronics devices.

Hensoldt's sensors equip platforms from the Eurofighter Typhoon to the Puma infantry fighting vehicle.

($1 = 0.8492 euros)

Reporting by Maria Rugamer; Editing by Matt Scuffham

Our Standards: The Thomson Reuters Trust Principles., opens new tab

The company is moving in the direction that the new CEO is pushing it.

Opendoor Technologies (OPEN 2.64%) has earned a spot as a stock to watch since changing CEOs in September and launching a growth plan.

In its first earnings report since implementing this new strategy, it demonstrated progress, and the stock jumped after earnings. However, it's still 86% off its all-time highs. Is this a spectacular buying opportunity?

Image source: Getty Images.

Getting back to growth The market had high hopes for Opendoor when it went public. As a real estate disruptor, it has an enormous opportunity to shake up a huge, largely traditional industry with its digital focus.

It would be convenient to blame an inhospitable operating environment for the company's fall, but new CEO Kaz Nejatian immediately set to work identifying how to run the business better. His four-pronged plan, announced in September, has these goals:

Reach break-even adjusted net income by the end of the year on a forward one-year basis. Increase transaction velocity to drive positive unit economics. Transition to more direct-to-consumer relationships. Expand product options. The turnaround plan shows early signs of progress. Opendoor says it's on track to achieve its goal of break-even adjusted net income by the end of the year, generating cash to cover operating expenses. However, that's a tall order, given the capital required to buy houses. Companies with this type of model typically raise debt to cover high-cost inventory. It can still become profitable, but it's not easy.

In terms of transaction velocity, which means speeding up the rate of transactions, management said that the October acquisitions cohort sold at more than twice the rate of the October 2024 cohort, with 50% already sold or under contract.

Opendoor increased acquisitions by 300% sequentially in the fourth quarter of 2025. In the last week of the quarter, it purchased 537 homes, up from 128 in the last week of the third quarter.

As for product expansion, it aims to offer more options for customers to move the needle. Its Cash Plus plan has become very popular, accounting for 35% of contracts in the last week of the quarter, up from 19% in the last week of the third quarter for a much smaller pool.

Today's Change

(

-2.64

%) $

-0.14

Current Price

$

4.97

Nejatian is rebuilding the company from the ground up, using artificial intelligence (AI) to run a smarter business, become more efficient, and give his team the tools and motivation to innovate and improve its systems.

Overall, the business is moving in the direction Nejatian is pushing it. Focusing on volume rather than spread, or the home's markup, is driving momentum, and giving customers greater flexibility is closing more deals. Using AI is helping it achieve profitability, but the positive results so far are very short-term and are mostly showing up in reference to the October cohort.

It's going to take more time The market responded well to the news, but the numbers were still depressing. Year over year, nearly every metric was worse, from revenue and gross margin to homes bought and sold. Adjusted net loss improved, however, from $77 million to $62 million.

I think the company is showing signs of life, and over a long time period, it could be an exciting growth story. If you have a high appetite for risk and can afford to lose what you invest, you might want to take a small chance on Opendoor stock. But most investors should continue to wait and watch until there's greater stability and more progress.